Biologics

Here are four updates in spine and orthopedic biologics since Nov. 6. 1. Xtant Medical’s CollagenX wound healing product is out in a full commercial launch. CollagenX can be used by cases that Xtant Medical’s spine and orthopedics biologics portfolio…

A 24-month study of Cerapedics’ PearlMatrix P-15 peptide enhanced bone graft found it had better time-to-fusion and clinical success than a local autograft, according to a Dec. 17 news release. Five things to know: 1. The controlled IDE study included…

Xtant Medical released its nanOss Strata synthetic bone graft in a commercial launch, according to a Dec. 11 news release. The bone graft is manufactured from hydroxycarbonapatite, which is more soluble than traditional hydroxyapatite. The bone graft is designed to…

The American Academy of Orthopaedic Surgeons has established the AAOS Orthobiologics Registry to measure the long-term safety, efficacy and outcomes, according to a Dec. 5 news release. The registry is designed to collect data for orthobiologics therapies for patients with…

For its groundbreaking work in sustaining global health systems in a year of geopolitical turbulence, Xenco Medical has been awarded the prestigious Excellence in Governance and Leadership for Global Challenges Award by the World Economic Forum for its role in…

Spine biologics companies are navigating unprecedented commercial pressure and accelerating technological change.  As demand for regenerative solutions grows and competition intensifies, leaders are forming strategic partnerships to strengthen distribution channels, advance product pipelines and meet surgeon expectations. The pace of…

Melville, N.Y.-based BioRestorative Therapies has secured a Type B meeting with the FDA to discuss an accelerated approval path for its fast-track-designated BRTX-100 program for chronic lumbar disc disease. The meeting is scheduled for mid-December. In a Nov. 17 news…

Here are spine spine and orthobiologics technologies that have received FDA approval so far this year, as reported by Becker’s.  Note: This list is not exhaustive. 

Regenerative medicine in spine and orthopedics is a promising area of care with medtech companies pushing into the space and physicians exploring their options. Here’s what spine and orthopedic experts predict for the short- and long-term. In 12 months Brian…

Vivek Babaria, DO, FAAPMR, is cautiously optimistic about what’s next for regenerative medicine, and as an interventional spine and sports medicine physician, he’s focused on the data that will drive it forward. Dr. Babaria of DISC Sports & Spine Center,…